It may be explained by the observation that T1DM patients with positive antibodies to glutamic acid decarboxylase (anti-GAD) are significantly more likely to have anti-TPO and anti-TG (Witek et al., 2012; Hansen et al., 2015). This evidence concerns the gene TPO and type 1 diabetes mellitus.